HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Departamento
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (20)
2023
-
Clinical description, molecular delineation and genotype-phenotype correlation in 340 patients with KBG syndrome: Addition of 67 new patients
Journal of Medical Genetics, Vol. 60, Núm. 7, pp. 644-654
-
Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial
Journal of Bone and Mineral Research, Vol. 38, Núm. 4, pp. 471-479
-
Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management
Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 555-563
2022
-
Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)
Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12
2021
-
Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial
Journal of Bone and Mineral Research, Vol. 36, Núm. 10, pp. 1967-1978
-
Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study
Journal of Clinical Oncology, Vol. 39, Núm. 28, pp. 3118-3127
-
Recomendaciones de la SEIOMM en la prevención y tratamiento del déficit de vitamina D
Revista de Osteoporosis y Metabolismo Mineral, Vol. 13, Núm. 2, pp. 84-97
-
The role of bronchoscopy in patients with sars-cov-2 pneumonia
ERJ Open Research, Vol. 7, Núm. 3
2020
-
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
Breast, Vol. 54, pp. 286-292
-
Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)
European Journal of Cancer Care, Vol. 29, Núm. 4
2019
-
A novel human Cdh1 mutation impairs anaphase promoting complex/cyclosome activity resulting in microcephaly, psychomotor retardation, and epilepsy
Journal of Neurochemistry, Vol. 151, Núm. 1, pp. 103-115
-
Spanish Results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II)
Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1020-1030
2018
-
Safety and efficacy of cryoablation vs. radiofrequency ablation of septal accessory pathways: Systematic review of the literature andmeta-analyses
Europace, Vol. 20, Núm. 8, pp. 1334-1342
-
Severe, life-threatening phenotype of primary Sjögren's syndrome: Clinical characterisation and outcomes in 1580 patients (the GEAS-SS Registry)
Clinical and Experimental Rheumatology, Vol. 36, pp. S121-S129
2017
-
Characterization and risk estimate of cancer in patients with primary Sjögren syndrome
Journal of Hematology and Oncology, Vol. 10, Núm. 1
2015
-
Differential Responses of the Septal Ventricle and the Atrial Signals during Ongoing Entrainment: A Method to Differentiate Orthodromic Reciprocating Tachycardia Using Septal Accessory Pathways from Atypical Atrioventricular Nodal Reentry
Circulation: Arrhythmia and Electrophysiology, Vol. 8, Núm. 5, pp. 1201-1209
2014
-
Documento de consenso: Recomendaciones para el manejo de la enfermedad ósea metabólica en pacientes con virus de la inmunodeficiencia humana
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 4, pp. 250-258
-
Simplification of risk stratification for splenic marginal zone lymphoma: A point-based score for practical use
Leukemia and Lymphoma
2012
-
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: Development and validation on 593 cases
British Journal of Haematology, Vol. 159, Núm. 2, pp. 164-171
-
Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series
Leukemia and Lymphoma, Vol. 53, Núm. 5, pp. 812-819